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OBJECTIVE: To assess the acute metabolic and cardiovascular responses to walking exercise at an intensity
corresponding to the heart rate of claudication pain onset and to investigate the effects of a 12-week walking
training program at this intensity on walking capacity.
METHODS: Twenty-nine patients with intermittent claudication were randomly allocated to the walking
training (n = 17) or control (CO, n = 12) group. The walking training group performed an acute exercise session
comprising 1562-min bouts of walking at the heart rate of claudication pain onset, with 2-min interpolated rest
intervals. The claudication symptoms and cardiovascular and metabolic responses were evaluated. Walking
training was then performed at the same intensity twice each week for 12 weeks, while the control group
engaged in twice weekly stretching classes. The claudication onset distance and total walking distance were
evaluated before and after the interventions. Brazilian Registry Clinical Trials: RBR-7M3D8W.
RESULTS: During the acute exercise session, the heart rate was maintained within tight limits. The exercise
intensity was above the anaerobic threshold and .80% of the heart rate peak and VO2peak. After the exercise
training period, the walking exercise group (n = 13) showed increased claudication onset distance (309¡153 vs.
413¡201m) and total walking distance (784¡182 vs. 1,100¡236m) compared to the control group (n = 12)
(p,0.05).
CONCLUSION: Walking exercise prescribed at the heart rate of claudication pain onset enables patients with
intermittent claudication to exercise with tolerable levels of pain and improves walking performance.
KEYWORDS: Peripheral Artery Disease; Functional Capacity; Exercise Intensity; Cardiovascular System;
Metabolism.
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& INTRODUCTION
Walking exercise is recommended for patients with
intermittent claudication (1,2) because it improves the
claudication onset distance and total walking distance.
However, the degree of improvement varies according to
different studies (3); this discrepancy might be explained by
different exercise prescriptions that vary in intensity,
duration and total amount of exercise prescribed (3–5).
Guidelines recommend that walking exercise should be
performed at an intensity that elicits claudication symptoms
within 3 to 5 min (1,2). However, the intensity of exercise
needed to elicit claudication symptoms in 3 min is greater than
that needed to elicit symptoms in 5 min. Hence, because of the
variability in exercise training prescriptions, it is difficult to
understand the impact of exercise training intensity on the
changes in walking performance in this patient group and the
discrepant results among different trials (6,7). Furthermore,
the guidelines recommend that patients walk until they
achieve claudication ofmoderate severity before resting briefly
and repeating the exercise (2). However, this approach could
prevent patients from engaging in exercise rehabilitation
because of the level of pain experienced.
We have previously demonstrated in patients with
intermittent claudication that claudication pain onset
assessed during a graded treadmill test occurred at an
intensity that was higher than the individual’s anaerobic
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threshold (8). Exercise above the anaerobic threshold is
known to be an effective stimulus for inducing metabolic
and cardiovascular adaptations (9); therefore, exercise at
this intensity could effectively improve the walking capa-
cities of patients with intermittent claudication.
Walking exercise above the anaerobic threshold has
previously been prescribed for patients with cardiovascular
disease, and heart rate was used to prescribe and monitor
the exercise intensity (10). However, using heart rate to
control exercise intensity in patients with intermittent
claudication, whose capacity to exercise is limited by
ischemic leg pain, has not been previously investigated.
The present study, which was designed to test the
feasibility and efficacy of using the heart rate of claudication
pain onset to prescribe walking exercise for patients with
intermittent claudication, was the first step in analyzing the
utility of this type of exercise prescription. Thus, the
purpose of this study was to analyze the pain, cardiovas-
cular and metabolic responses experienced by patients
during walking exercise performed at the heart rate
corresponding to the claudication pain onset, and to
investigate the effects of a 12-week walking training
program at this intensity on walking capacity in patients
with intermittent claudication. We hypothesized that an
exercise prescription at this intensity would elicit tolerable
claudication symptoms, while inducing an exercise training
stimulus above the individual’s anaerobic threshold.
Second, we hypothesized that a low-volume walking
exercise training program at this intensity would induce
walking performance improvements in this patient group.
& MATERIAL AND METHODS
This study was approved by the Ethics Committee of the
School of Physical Education and Sport of University of Sa˜o
Paulo (process 2008/55) and was registered in the Brazilian
Registry of Clinical Trials (RBR-7M3D8W). Patients with
stable symptoms of intermittent claudication were recruited
from a tertiary center specializing in vascular disease. Male
patients with Fontaine stage II symptoms of intermittent
claudication for more than 6 months, an ankle-brachial
index #0.90 at rest in 1 or 2 legs and who were able to walk
for at least 2 min at 3.2 km/h on a treadmill were invited to
participate. The following exclusion criteria were applied:
obesity (body mass index $30 kg/m2), use of b-blockers,
non-dihydropyridine calcium channel blockers, or periph-
eral vasodilators, inability to obtain the ankle-brachial
index, exercise tolerance limited by factors other than
claudication (i.e., arrhythmias, cardiac symptoms or exag-
gerated blood pressure rise), electrocardiogram response
suggestive of myocardial ischemia and history of revascu-
larization in the previous year.
Twenty-nine patients participated in the study and were
randomized into 2 groups: the walking training group
(n= 17) and the control group (n = 12). The study comprised
2 phases. In phase 1, during an acute walking exercise
session conducted at intensity of heart rate of claudication
pain onset, the cardiopulmonary responses and claudication
symptoms were assessed in the patients who were
randomized to walking training. In phase 2, the patients
in the walking training group engaged in twice-weekly
walking exercise training for 12 weeks, while patients in the
control group engaged in stretching exercise classes for the
same amount of time. Both groups were evaluated at the
beginning and end of the 12-week period.
Maximal graded treadmill test
All patients performed a progressive graded treadmill
exercise test to maximum claudication pain at baseline and
after 12 weeks. Speed was maintained at 3.2 km/h, and the
grade was increased by 2% every 2 min (11). A 12-lead
electrocardiogram was continuously monitored, and the
heart rate was measured at the end of each stage. Oxygen
uptake (VO2) was continuously measured using a metabolic
cart (Medical Graphics Corp CPX/D, St Paul, Minnesota,
USA), and the data were averaged over 30-s intervals for use
in the analysis. The anaerobic threshold was independently
detected by 2 evaluators; the threshold was defined by a
nonlinear increase in the respiratory exchange ratio, carbon
dioxide production and ventilation, and an increase in the
end-tidal oxygen partial pressure and a decrease in the
ventilatory equivalent for oxygen (12). During the test,
patients reported the onset of claudication symptoms, and
the heart rate at this point was used for the walking exercise
training prescription. Claudication onset distance and total
walking distance were defined as the distance walked when
the patient first reported leg pain and the distance at which
the patient was unable to continue exercising because of leg
pain, respectively (13,14).
Phase 1: Acute exercise responses
Patients in the walking training group performed a
session of walking exercise that comprised 1562-min
walking bouts, with 2-min intermittent rest periods.
During each of the 2-min walking bouts, exercise intensity
was adjusted to maintain heart rate within 4 beats per
minute (bpm) above or below the heart rate of claudication
pain onset (e.g., if the patient reported the claudication pain
onset in the maximal treadmill test at 100 bpm, the heart
rate exercise zone was set at 96 to 104 bpm). The treadmill
speed was set at 3.2 km/h, while the grade was adjusted to
achieve the target heart rate, which was continuously
monitored (Polar A3, Helsink, Uusimaa, Finland). In
addition, the pain levels were monitored throughout the
session, and VO2 was measured during the 1
st, 5th and 12th
walking exercise bouts.
Phase 2: Exercise training intervention
Patients in the walking training group engaged in a twice-
weekly 12-week walking exercise training program that
consisted of the same protocol used in phase 1 of the study.
Each session comprised 1562-min walking exercise bouts at
the heart rate of claudication pain onset ¡ 4 bpm, with 2-
min interpolated rest periods. In all exercise training
sessions, the heart rate was continuously monitored. The
walking speed was set at 3.2 km/h, and the grade was
adjusted to maintain the heart rate within the target range. If
the patient failed to reach the target heart rate during a
particular walking exercise session, the treadmill grade was
increased for the next session. Patients in the control group
performed stretching exercises using the upper and lower
limbs twice a week for 30 min per session.
Statistical analysis
Chi-squared tests and t-tests were used to compare
the baseline characteristics of the groups. In phase 1, the
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acute responses to walking training were analyzed using a
one-way analysis of variance (ANOVA). In phase 2, the
claudication onset and total walking distances were
compared between the groups using a two-way ANOVA;
Newman-Keuls post-hoc tests were used to identify
differences. Significance was set at p,0.05. The data are
presented as the mean ¡ standard deviation (SD).
& RESULTS
The clinical characteristics of the patients with intermit-
tent claudication are shown in Table 1. Baseline anthropo-
metric and disease characteristics were similar between the
walking training and control groups. Most patients were
elderly, non-obese, hypertensive and were receiving anti-
hypertensive, lipid-lowering and antiplatelet drug therapy.
The acute responses assessed during the walking exercise
are presented in Table 2. Heart rate was maintained at the
target intensity throughout the acute exercise session (approxi-
mately 100% of the heart rate of claudication pain onset). In
comparison with the resting values, both the VO2 and heart
rate increased during the 1st, 5th and 12th exercise bouts. After
the 5th bout, the VO2 and heart rate were .80% of the peak
values recorded in the maximal graded treadmill test. After
the 5th bout most patients reported experiencing tolerable
claudication symptoms during walking.
Twenty-five patients completed phase 2 of the study. Four
patients in the walking training group did not complete the
training program for personal reasons. During the training
program, heart rate was kept at the target intensity by
increasing the treadmill grade as patients adapted to the
exercise program. After 12 weeks, the claudication onset
distance and total walking distance increased significantly
(p,0.05) in the walking training group, while no change
was observed in the control group (Table 3).
& DISCUSSION
Although regular walking exercise is recommended as an
initial treatment for many patients with intermittent
claudication, the exercise prescription intensity is poorly
defined in peripheral arterial disease guidelines (1,2). The
results of the present study indicate that walking exercise
prescribed at the heart rate corresponding to claudication
pain onset induces tolerable levels of ischemic leg pain and
a cardiopulmonary exercise stimulus that is above the
anaerobic threshold. Previous studies have suggested that
exercise intensities that evoke claudication symptoms are
important for improving walking capacity (3,7), and an
exercise stimulus which is above the anaerobic threshold is
particularly effective for promoting cardiovascular and
metabolic adaptations (9,15). Hence, our results show that
a walking exercise prescription at the heart rate of
Table 1 - Clinical characteristics of the study patients.
Control (n = 12) Walking training (n= 13) p-value
Age (years) 61¡8 64¡6 0.39
Weight (kg) 74.1¡13.6 70.7¡8.2 0.54
Body mass index (kg/m2) 25.9¡3.8 25.4¡2.3 0.73
ABI at rest 0.60¡0.03 0.61¡0.03 0.40
Iliofemoral (%) 50 38 0.69
Femoropopliteal (%) 33 46 0.68
Tibiofibular (%) 17 15 0.99
Claudication onset distance (m) 328¡161 309¡153 0.77
Total walking distance (m) 828¡286 784¡182 0.64
Cardiovascular Risk Factors and Comorbidities
Current smoking (%) 33 15 0.34
Hypertension (%) 83 84 0.93
Diabetes mellitus (%) 25 15 0.64
Dyslipidemia (%) 100 85 0.15
Medication
Antihypertensive agent (%) 83 84 0.93
Lipid-lowering agent (%) 50 77 0.12
Anticoagulants/antiplatelet agent (%) 92 100 0.28
Continuous variables are presented as the mean ¡ SD.
ABI = ankle brachial index.
Table 2 - Cardiopulmonary responses and prevalence of claudication symptoms evaluated during a walking training
session performed with the intensity prescribed at the heart rate of claudication pain onset (n = 17).
Rest 1st bout 5th bout 12th bout
VO2 (ml.kg
21.min21) 4.0¡0.8 12.0¡3.3a 14.9¡2.2ab 14.7¡2.7ab
VO2 peak (%) 22¡7 65¡20
a 81¡16ab 80¡16ab
VO2 anaerobic threshold (%) 32¡9 94¡33
a 117¡27ab 114¡27ab
Heart rate (bpm) 73¡10 94¡13a 99¡16a 101¡16a
Heart rate peak (%) 60¡13 76¡6a 81¡8a 82¡7ab
Heart rate of claudication pain onset (%) — 95¡7 100¡3b 102¡5b
Pain (% patients) — 47 94 100
Continuous variables are presented as the mean ¡ SD.
aSignificant difference from rest (p,0.05).
bSignificant difference from the 1st bout (p,0.05). VO2: oxygen uptake.
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claudication pain onset is consistent with the physiological
evidence for optimal exercise training intensity to improve
walking performance and aerobic exercise tolerance in this
patient group. Furthermore, patients can exercise at this
intensity without experiencing intolerable levels of ischemic
leg pain.
This conclusion is supported by the patient responses to
the exercise training program. Twelve hours of walking
exercise at the heart rate of claudication pain onset spread
over 12 weeks induced improvements (in the claudication
onset distance and total walking distance) that were similar
in magnitude to the improvements previously observed
after higher volume walking exercise training programs in
patients with intermittent claudication (16–18). Claudi-
cation onset distance and total walking distance were
increased by 104¡141 m and 316¡141 m, respectively,
which represent clinically meaningful changes, particularly
because our patient cohort had a higher walking capacity at
baseline than that reported in previous studies (3,5,7).
Evidence from a previous meta-analysis suggests that for
optimal improvements in walking capacity, exercise ses-
sions should be .30 min in duration and should be
performed at least 3 times per week for a minimum of 6
months (3). Our evidence suggests that walking exercise
prescribed at the heart rate corresponding to the claudica-
tion pain onset in the form of short bouts is an effective
exercise training regimen that can induce walking perfor-
mance improvements comparable to those of higher volume
walking exercise programs in patients with intermittent
claudication. Furthermore, exercise training at the heart rate
of claudication pain onset is well tolerated by patients and
can be easily controlled in the clinic or community setting
using a heart rate monitor.
The present study had limitations. The proposed walking
training protocol focused only on the exercise intensity;
exercise duration and frequency may also influence
responses to walking training. However, these parameters
can be objectively stated and did not vary greatly between
the studies. The present investigation did not include
women and did not include patients who were using beta-
blockers or non-dihydropyridine calcium channel blockers;
thus, the results cannot be extrapolated to patients with
intermittent claudication with those characteristics. In
addition, we did not include patients using vasodilators,
such as cilostazol, which are used by some patients and
might improve walking distance. Thus, the results might
change with vasodilator treatment, which should be tested
in the future. Finally, in this study, our control group
followed another type of training and did not employ the
traditional walking prescription for intermittent claudica-
tion patients. Therefore, it was not possible to determine
whether this study’s exercise protocol was better than, equal
to or worse than others. This study was intended to be the
first step in verifying whether the protocol as feasible and
resulted in walking improvements. Future research should
compare this protocol with other classical training protocols.
In conclusion, walking exercise prescribed at an intensity
corresponding to the heart rate of claudication pain onset
induces tolerable levels of ischemic leg pain and a
cardiopulmonary exercise training stimulus that is above
the anaerobic threshold (.80% of peak aerobic capacity). A
short-term, low-volume exercise training program at this
intensity is effective in evoking clinically meaningful
improvements in walking performance in this patient
group. Hence, the heart rate of claudication pain onset
may be useful for optimizing exercise prescriptions in
patients with intermittent claudication.
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